In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.

We examined 300 strains of Neisseria gonorrhoeae and 100 strains of Haemophilus ducreyi to determine their in vitro susceptibility to two new cephalosporins, cefetamet (Ro 15-8074) and ceftetrame (Ro 19-5247; T-2588), and a new fluroquinolone, fleroxacin (Ro 23-6240; AM-833). Their activity was comp...

詳細記述

保存先:

書誌詳細
出版年:	Antimicrob Agents Chemother
主要な著者:	Le Saux, N M, Slaney, L A, Plummer, F A, Ronald, A R, Brunham, R C
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1987
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174890/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2959199/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.7.1153
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.

類似資料